LeafNLP Demos
Back to explore

Report #2877282

Received Dec 10, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
1.5 yrs
State
NV
Recovered
Unknown
Vaccinated
Dec 4, 2025
Onset
Dec 4, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPAHEP A (HAVRIX)GLAXOSMITHKLINE BIOLOGICALS2UNK—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

Second dose given 5 days early; This non-serious case was reported by a other health professional via sales rep and described the occurrence of drug dose administration interval too short in a 18-month-old male patient who received HAV (Havrix 720 Junior) for prophylaxis. Previously administered products included Havrix 720 (1st dose taken on 09-JUN-2025). On 04-DEC-2025, the patient received the 2nd dose of Havrix 720 Junior. On 04-DEC-2025, an unknown time after receiving Havrix 720 Junior, the patient experienced drug dose administration interval too short (Verbatim: Second dose given 5 days early). The outcome of the drug dose administration interval too short was not applicable. Additional Information: GSK receipt date 04-DEC-2025 The batch number was not provided and a request for this information has been made.